211 related articles for article (PubMed ID: 17363573)
1. Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1.
Shen JC; Unoki M; Ythier D; Duperray A; Varticovski L; Kumamoto K; Pedeux R; Harris CC
Cancer Res; 2007 Mar; 67(6):2552-8. PubMed ID: 17363573
[TBL] [Abstract][Full Text] [Related]
2. Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility.
Unoki M; Shen JC; Zheng ZM; Harris CC
J Biol Chem; 2006 Nov; 281(45):34677-86. PubMed ID: 16973615
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and functional characterization of the interaction between liprin-α1 and GIT1: implications for the regulation of cell motility.
Asperti C; Astro V; Pettinato E; Paris S; Bachi A; de Curtis I
PLoS One; 2011; 6(6):e20757. PubMed ID: 21695141
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of ING4 mediated inhibition of the proliferation and migration of human glioma cell line U251].
Zhan LP; Li QY; Zhang Y; Zhang TJ; Yuan ZC; Lu PS
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Nov; 27(11):1188-90. PubMed ID: 22078444
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated ING4 expression suppresses pancreatic carcinoma cell growth via induction of cell-cycle alteration, apoptosis, and inhibition of tumor angiogenesis.
Xie YF; Sheng W; Xiang J; Zhang H; Ye Z; Yang J
Cancer Biother Radiopharm; 2009 Apr; 24(2):261-9. PubMed ID: 19409049
[TBL] [Abstract][Full Text] [Related]
6. Role of ING4 in human melanoma cell migration, invasion and patient survival.
Li J; Martinka M; Li G
Carcinogenesis; 2008 Jul; 29(7):1373-9. PubMed ID: 18375955
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle regulator ING4 is a suppressor of melanoma angiogenesis that is regulated by the metastasis suppressor BRMS1.
Li J; Li G
Cancer Res; 2010 Dec; 70(24):10445-53. PubMed ID: 21056991
[TBL] [Abstract][Full Text] [Related]
8. Liprin-α1 modulates cancer cell signaling by transmembrane protein CD82 in adhesive membrane domains linked to cytoskeleton.
Pehkonen H; Lento M; von Nandelstadh P; Filippou A; Grénman R; Lehti K; Monni O
Cell Commun Signal; 2018 Jul; 16(1):41. PubMed ID: 30005669
[TBL] [Abstract][Full Text] [Related]
9. Reduced ING4 Expression Is Associated with the Malignancy of Human Bladder.
Wang Y; Wang T; Han Y; Wu H; Zhao W; Tong D; Wei L; Zhong Z; An R; Wang Y
Urol Int; 2015; 94(4):464-71. PubMed ID: 25790869
[TBL] [Abstract][Full Text] [Related]
10. Liprin-α1 contributes to oncogenic MAPK signaling by counteracting ERK activity.
Pehkonen H; Filippou A; Väänänen J; Lindfors I; Vänttinen M; Ianevski P; Mäkelä A; Munne P; Klefström J; Toppila-Salmi S; Grénman R; Hagström J; Mäkitie AA; Karhemo PR; Monni O
Mol Oncol; 2024 Mar; 18(3):662-676. PubMed ID: 38264964
[TBL] [Abstract][Full Text] [Related]
11. Role of Liprins in the Regulation of Tumor Cell Motility and Invasion.
Chiaretti S; de Curtis I
Curr Cancer Drug Targets; 2016; 16(3):238-48. PubMed ID: 26882029
[TBL] [Abstract][Full Text] [Related]
12. Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma.
Li XH; Kikuchi K; Zheng Y; Noguchi A; Takahashi H; Nishida T; Masuda S; Yang XH; Takano Y
Oral Oncol; 2011 Mar; 47(3):217-23. PubMed ID: 21310648
[TBL] [Abstract][Full Text] [Related]
13. Liprin-α1 regulates breast cancer cell invasion by affecting cell motility, invadopodia and extracellular matrix degradation.
Astro V; Asperti C; Cangi MG; Doglioni C; de Curtis I
Oncogene; 2011 Apr; 30(15):1841-9. PubMed ID: 21151172
[TBL] [Abstract][Full Text] [Related]
14. Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo.
Li Z; Xie Y; Sheng W; Miao J; Xiang J; Yang J
Cancer Biother Radiopharm; 2010 Aug; 25(4):427-37. PubMed ID: 20707719
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑214 upregulates HIF‑1α and VEGF by targeting ING4 in lung cancer cells.
Li Y; Zhao L; Qi Y; Yang X
Mol Med Rep; 2019 Jun; 19(6):4935-4945. PubMed ID: 31059086
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor of growth-4 mediates chromatin modification and has a suppressive effect on tumorigenesis and innate immunity.
Mathema VB; Koh YS
Tumour Biol; 2012 Feb; 33(1):1-7. PubMed ID: 21971889
[TBL] [Abstract][Full Text] [Related]
17. ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.
Chen Y; Huang Y; Hou P; Zhang Z; Zhang Y; Wang W; Sun G; Xu L; Zhou J; Bai J; Zheng J
Oncotarget; 2016 Nov; 7(48):79017-79031. PubMed ID: 27806345
[TBL] [Abstract][Full Text] [Related]
18. Two wobble-splicing events affect ING4 protein subnuclear localization and degradation.
Tsai KW; Tseng HC; Lin WC
Exp Cell Res; 2008 Oct; 314(17):3130-41. PubMed ID: 18775696
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor of growth 4 is involved in melanomagenesis and induces growth suppression and apoptosis in melanoma cell line M14.
Cai L; Li X; Zheng S; Wang Y; Wang Y; Li H; Yang J; Sun J
Melanoma Res; 2009 Feb; 19(1):1-7. PubMed ID: 19430401
[TBL] [Abstract][Full Text] [Related]
20. Liprin-α1 is a regulator of vimentin intermediate filament network in the cancer cell adhesion machinery.
Pehkonen H; von Nandelstadh P; Karhemo PR; Lepikhova T; Grenman R; Lehti K; Monni O
Sci Rep; 2016 Apr; 6():24486. PubMed ID: 27075696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
